BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31208361)

  • 1. Molecular genetic characterization reveals linear tumor evolution in a pulmonary sarcomatoid carcinomas patient with a novel PHF20-NTRK1 fusion: a case report.
    Ge J; Yao B; Huang J; Wu X; Bao H; Ou Q; Shao YW; Chen J
    BMC Cancer; 2019 Jun; 19(1):592. PubMed ID: 31208361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer.
    Xia H; Xue X; Ding H; Ou Q; Wu X; Nagasaka M; Shao YW; Hu X; Ou SI
    Clin Lung Cancer; 2020 May; 21(3):247-254. PubMed ID: 31761448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel NCOR2-NTRK1 fusion detected in a patient of lung adenocarcinoma and response to larotrectinib: a case report.
    Zhang L; Liu H; Tian Y; Wang H; Yang X
    BMC Pulm Med; 2021 Apr; 21(1):125. PubMed ID: 33865348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report.
    Zhou N; Schäfer R; Li T; Fang M; Liu L
    BMC Cancer; 2018 Aug; 18(1):842. PubMed ID: 30134855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.
    Park DY; Choi C; Shin E; Lee JH; Kwon CH; Jo HJ; Kim HR; Kim HS; Oh N; Lee JS; Park OK; Park E; Park J; Shin JY; Kim JI; Seo JS; Park HD; Park J
    Oncotarget; 2016 Feb; 7(7):8399-412. PubMed ID: 26716414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
    J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of biomarkers in patients with sarcomatoid carcinoma of the lung: molecular analysis of 33 cases.
    Jiang X; Liu Y; Chen C; Zhan Z; Yan Q; Guo Y; Wang Q; Li K
    Clin Lung Cancer; 2012 Jul; 13(4):288-96. PubMed ID: 22169481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterisation of sarcomatoid carcinomas reveals multiple novel actionable mutations and identifies
    Ding Y; Shao Y; Na C; Yin JC; Hua H; Tao R; Jiang Y; Hu R; He X; Miao C; Zhu D; Zhang Z
    J Med Genet; 2022 Jan; 59(1):10-17. PubMed ID: 33115932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stepwise addition of genetic changes correlated with histological change from "well-differentiated" to "sarcomatoid" phenotypes: a case report.
    Goto T; Hirotsu Y; Mochizuki H; Nakagomi T; Oyama T; Amemiya K; Omata M
    BMC Cancer; 2017 Jan; 17(1):65. PubMed ID: 28103823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
    Schrock AB; Li SD; Frampton GM; Suh J; Braun E; Mehra R; Buck SC; Bufill JA; Peled N; Karim NA; Hsieh KC; Doria M; Knost J; Chen R; Ou SI; Ross JS; Stephens PJ; Fishkin P; Miller VA; Ali SM; Halmos B; Liu JJ
    J Thorac Oncol; 2017 Jun; 12(6):932-942. PubMed ID: 28315738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular classification of pulmonary sarcomatoid carcinomas suggests new therapeutic opportunities.
    Pécuchet N; Vieira T; Rabbe N; Antoine M; Blons H; Cadranel J; Laurent-Puig P; Wislez M
    Ann Oncol; 2017 Jul; 28(7):1597-1604. PubMed ID: 28419182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.
    Fallet V; Saffroy R; Girard N; Mazieres J; Lantuejoul S; Vieira T; Rouquette I; Thivolet-Bejui F; Ung M; Poulot V; Schlick L; Moro-Sibilot D; Antoine M; Cadranel J; Lemoine A; Wislez M
    Ann Oncol; 2015 Aug; 26(8):1748-53. PubMed ID: 25969368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Inv(1)(q23q31)
    Rekhi B; Shetty O; Bapat P; Gurav M; Qureshi S
    Int J Surg Pathol; 2021 Feb; 29(1):102-108. PubMed ID: 32489127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal cell carcinosarcoma with PTCH1 mutations in both epithelial and sarcomatoid primary tumor components and in the sarcomatoid metastasis.
    Kiuru M; McDermott G; Coit DC; Berger MF; Busam KJ
    Am J Surg Pathol; 2014 Jan; 38(1):138-42. PubMed ID: 24335643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity and predictive biomarker for pulmonary sarcomatoid carcinomas.
    Qin J; Chen B; Li C; Yan J; Lu H
    Cancer Genet; 2021 Jan; 250-251():12-19. PubMed ID: 33217678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy.
    Italiano A; Cortot AB; Ilie M; Martel-Planche G; Fabas T; Pop D; Mouroux J; Hofman V; Hofman P; Pedeutour F
    Int J Cancer; 2009 Nov; 125(10):2479-82. PubMed ID: 19681124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors.
    Agaram NP; Zhang L; Sung YS; Chen CL; Chung CT; Antonescu CR; Fletcher CD
    Am J Surg Pathol; 2016 Oct; 40(10):1407-16. PubMed ID: 27259011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment.
    Chen W; Wang H; Jiang D; Luan L; Zhou Y; Hou Y
    World J Surg Oncol; 2021 Apr; 19(1):136. PubMed ID: 33941195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing analysis identifies genomic alterations in pathological morphologies: A case of pulmonary carcinosarcoma harboring EGFR mutations.
    Koba H; Kimura H; Nishikawa S; Sone T; Abo M; Hara J; Hosomichi K; Tajima A; Kasahara K
    Lung Cancer; 2018 Aug; 122():146-150. PubMed ID: 30032823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maxillary carcinosarcoma: Identification of a novel MET mutation in both carcinomatous and sarcomatous components through next generation sequencing.
    Ando M; Saito Y; Morikawa T; Omura G; Kobayashi K; Akashi K; Yoshida M; Ebihara Y; Fujimoto C; Fukayama M; Yamasoba T; Asakage T
    Head Neck; 2015 Dec; 37(12):E179-85. PubMed ID: 25782598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.